The apolipoprotein E (Apo E) epsilon 4 allele has been associated with parietal metabolic abnormalities and asymmetries in asymptomatic subjects at risk for Alzheimer disease (AD). However, previous research has shown minimal effect of the epsilon 4 allele on regional cerebral blood flow (rCBF) and metabolism in patients with probable AD.Objective
To determine whether the Apo E epsilon 4 allele is associated with parietal rCBF abnormalities and asymmetries in patients with probable AD.Patients and Methods
Thirty patients with AD with the epsilon 4 allele (epsilon 4+ AD), 22 patients with AD without the epsilon 4 allele (epsilon 4- AD), and 14 healthy control subjects underwent single-photon emission computed tomography (SPECT) scanning with 740 MBq technetium Tc 99m hexamethylpropyleneamine oxime. Ratios of parietal-unaffected regions and a left-right parietal asymmetry index were compared between both patient groups.Results
The group with epsilon 4- AD was younger (P=.005, Student t test) and had an earlier age of onset (P=.005) than the group with epsilon 4+ AD. Analysis of covariance revealed no significant difference in the parietal rCBF ratio, controlling for age of onset and Mini-Mental State Examination score (F (1),48 =0.06; P =.81). However, contrary to hypothesis, significantly greater parietal rCBF asymmetry was seen in patients with epsilon 4 - AD (mean +/- SD, 9.7% +/- 5.5%) than those with epsilon 4+ AD (6.3% +/- 4.7%; F1,50 =5.89; P =.02; analysis of variance). When number of epsilon 4 allele copies was considered, this effect appeared to accrue primarily from a difference between patients with 0 and with 2 epsilon 4 allele copies. An exploratory analysis of multiple cortical structures suggested that this asymmetry extended to additional regions (superior temporal) and to combined association cortex.Conclusions
Greater parietal rCBF asymmetry is involved in epsilon 4 - AD than in epsilon 4+ AD. Lack of the epsilon 4 allele may be associated with other (as yet undiscovered) genetic or environmental risk factors, which confer greater neuropathological asymmetry.